Effects of Fish Oil Supplementation on Markers of the Metabolic Syndrome
- 1 September 2010
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 157 (3), 395-400.e1
- https://doi.org/10.1016/j.jpeds.2010.04.001
Abstract
No abstract availableKeywords
Funding Information
- Strategiske Forskningsråd
This publication has 34 references indexed in Scilit:
- A Systemic Review of the Roles of n-3 Fatty Acids in Health and DiseaseJournal of the American Dietetic Association, 2009
- Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adultsDiabetologia, 2008
- Effect of the dietary fat quality on insulin sensitivityBritish Journal of Nutrition, 2008
- n-3 Fatty Acids Preserve Insulin Sensitivity In Vivo in a Peroxisome Proliferator–Activated Receptor-α–Dependent MannerDiabetes, 2007
- Effects of n−3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidationThe American Journal of Clinical Nutrition, 2006
- Blood pressure response to fish oil supplementation: metaregression analysis of randomized trialsJournal Of Hypertension, 2002
- Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic menThe American Journal of Clinical Nutrition, 2000
- Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acidsThe American Journal of Clinical Nutrition, 1997
- Does fish oil lower blood pressure? A meta-analysis of controlled trials.Circulation, 1993
- Fish Oil Prevents Insulin Resistance Induced by High-Fat Feeding in RatsScience, 1987